Dark

RDHL
Redhill Biopharma Ltd.
stock NASDAQ ADR

At Close

May 8, 2025 3:59:30 PM EDT

1.98USD+3.459%(+0.07)40,206

0.00Bid 0.00Ask 0.00Spread

Pre-market

May 8, 2025 8:58:30 AM EDT

1.85USD-3.334%(-0.06)1,924

After-hours

Dec 31, 1969 7:00:00 PM EST

0.00USD0.000%(0.00)0

OverviewHistoricalExchangesShortsMore

open chart

Market Cap

3.50M

CEO

Dror Ben-Asher

Headquarters

21 Haarbaa St, Tel Aviv Yafo, Israel

Industry

Drug Manufacturers-Specialty & Generic

Last Split

Aug 20, 20241for25reverse

GSK SNY MRK TARO TEVA XLV

RDHL Stats

Avg. Vol. 10 Day

41,260

Avg. Vol. 30 Day

302,187

Employees

113

Market Cap

3,502,858

Shares Out.

1,769,120

On/Off Exchange

64%/36%

6 Month Beta

1.10

1 Year Beta

0.76

2 Year Beta

0.53

3 Year Beta

0.82

52 Week Low

1.72

52 Week High

20.28

SMA50

2.60

SMA200

6.63

1 Week

-7.91%

1 Month

-15.39%

3 Month

-64.00%

6 Month

-75.40%

1 Year

-82.49%

2 Year

-96.69%

5 Year

-99.97%

Profile

redhill biopharma is a biopharmaceutical company focused primarily on development of late clinical-stage new, improved and patented formulations of existing drugs. redhill has an experienced management team, board of directors and advisory board based in israel, the us, canada and europe, with successful track record at big and small pharma of bringing patented drugs to the market, as well as extensive managerial, financial, and transactional expertise

RDHL Stock Summary

Redhill Biopharma Ltd. (NASDAQ:RDHL) stock price today is $1.98, and today's volume is 40,206. RDHL is up 3.459% today. The 30 day average volume is 302,187. RDHL market cap is 3.50M with 1,769,120 shares outstanding.